CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.68%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.74B
Cap. Flow
% of AUM
99.08%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$84.5M |
| 2 |
Gilead Sciences
GILD
|
+$83.7M |
| 3 |
Apple
AAPL
|
+$79.3M |
| 4 |
Qualcomm
QCOM
|
+$74.7M |
| 5 |
Amgen
AMGN
|
+$73M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.71% |
| 4 | Industrials | 8% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
NiSource
NI
$19.2B
| $2.99M | 0.06% |
+179,466
| New | +$2.99M |
|
|
IMGN
302
DELISTED
Immunogen Inc
IMGN
| $2.96M | 0.06% |
+485,000
| New | +$2.96M |
|
303
BCE
BCE
$22.5B
| $2.88M | 0.06% |
+62,632
| New | +$2.88M |
|
304
US Bancorp
USB
$76.5B
| $2.87M | 0.06% |
+63,744
| New | +$2.87M |
|
|
YHOO
305
DELISTED
Yahoo Inc
YHOO
| $2.86M | 0.06% |
+56,707
| New | +$2.86M |
|
306
Expedia Group
EXPE
$26.6B
| $2.83M | 0.06% |
+33,103
| New | +$2.83M |
|
307
Agios Pharmaceuticals
AGIO
$2.08B
| $2.8M | 0.06% |
+25,000
| New | +$2.8M |
|
|
SPPI
308
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $2.77M | 0.06% |
+400,000
| New | +$2.77M |
|
309
Halozyme
HALO
$8.88B
| $2.75M | 0.06% |
+285,000
| New | +$2.75M |
|
310
Cencora
COR
$57.6B
| $2.75M | 0.06% |
+30,494
| New | +$2.75M |
|
311
T-Mobile US
TMUS
$271B
| $2.75M | 0.06% |
+102,001
| New | +$2.75M |
|
312
iShares MSCI Emerging Markets ETF
EEM
$19.6B
| $2.7M | 0.06% |
+68,982
| New | +$2.7M |
|
313
Zions Bancorporation
ZION
$8.48B
| $2.68M | 0.06% |
+94,149
| New | +$2.68M |
|
|
CTIC
314
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.66M | 0.06% |
+112,500
| New | +$2.66M |
|
315
Puma Biotechnology
PBYI
$231M
| $2.65M | 0.06% |
+14,000
| New | +$2.65M |
|
316
Altria Group
MO
$112B
| $2.59M | 0.05% |
+52,554
| New | +$2.59M |
|
|
UN
317
DELISTED
Unilever NV New York Registry Shares
UN
| $2.58M | 0.05% |
+66,000
| New | +$2.58M |
|
318
Celldex Therapeutics
CLDX
$1.67B
| $2.56M | 0.05% |
+9,333
| New | +$2.56M |
|
319
Ovintiv
OVV
$11B
| $2.55M | 0.05% |
+36,554
| New | +$2.55M |
|
|
RDUS
320
DELISTED
Radius Health, Inc.
RDUS
| $2.53M | 0.05% |
+65,000
| New | +$2.53M |
|
321
Phillips 66
PSX
$52.9B
| $2.52M | 0.05% |
+35,174
| New | +$2.52M |
|
322
Adobe
ADBE
$148B
| $2.52M | 0.05% |
+34,623
| New | +$2.52M |
|
323
HCA Healthcare
HCA
$92.5B
| $2.48M | 0.05% |
+33,824
| New | +$2.48M |
|
324
Leggett & Platt
LEG
$1.33B
| $2.47M | 0.05% |
+58,056
| New | +$2.47M |
|
325
APA Corp
APA
$8.18B
| $2.46M | 0.05% |
+39,262
| New | +$2.46M |
|